Trade OBIO stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Orchestra BioMed Holdings, Inc. (OBIO) is trading at US$5.64, down 1.40% today as of Oct 14, 16:00 EDT. The company has a market capitalisation of US$322.16M. Over the past 52 weeks, OBIO has traded between US$3.26 and US$6.50. On Syfe you can trade OBIO with $0 commission and add it to your watchlist.
| Previous close | US$5.72 |
|---|---|
| Market cap | US$322.16M |
| 52-week range | US$3.26 – US$6.50 |
| Volume | 222.88K |
| Exchange | US |
Orchestra BioMed Holdings, Inc.
Orchestra Biomed Holdings, Inc. engages in the provision of biomedical technologies to patients through risk-reward-sharing partnerships with medical device companies. The company was founded by David P. Hochman on May 25, 2020 and is headquartered in New Hope, PA.
Year: 2023
Sector Update: Healthcare Stocks Softer Late Afternoon
Sep 10, 7:49 PM · MT Newswires
Sector Update: Healthcare
Sep 10, 7:27 PM · MT Newswires
Orchestra BioMed Shares Rise After BTIG Upgrade
Sep 10, 7:11 PM · MT Newswires
Orchestra BioMed Holdings, Inc. (OBIO) stock is trading at US$5.64, -1.40% from the previous close of US$5.72.
The market cap for Orchestra BioMed Holdings, Inc. (OBIO) stock is approximately US$322.16M.
The 52-week high for Orchestra BioMed Holdings, Inc. (OBIO) stock is US$6.50.
The 52-week low for Orchestra BioMed Holdings, Inc. (OBIO) stock is US$3.26.
Orchestra BioMed Holdings, Inc. (OBIO) does not currently pay a dividend.
Stay on top of OBIO
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
